C&R Research Inc. (KOSDAQ:359090)

South Korea flag South Korea · Delayed Price · Currency is KRW
898.00
+17.00 (1.93%)
At close: Jan 29, 2026
-20.88%
Market Cap51.61B
Revenue (ttm)63.97B +4.5%
Net Income2.80B -53.6%
EPS49.15 -53.2%
Shares Out57.47M
PE Ratio18.27
Forward PEn/a
Dividend10.00 (1.14%)
Ex-Dividend DateDec 29, 2025
Volume160,439
Average Volume197,598
Open890.00
Previous Close881.00
Day's Range871.00 - 898.00
52-Week Range805.00 - 1,216.00
Beta0.07
RSI50.54
Earnings DateFeb 11, 2026

About C&R Research

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company was founded in 1997 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 1997
Employees 510
Stock Exchange KOSDAQ
Ticker Symbol 359090
Full Company Profile

Financial Performance

In 2024, C&R Research's revenue was 59.69 billion, an increase of 8.32% compared to the previous year's 55.10 billion. Earnings were 3.84 billion, a decrease of -30.99%.

Financial Statements